The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

South Korean clinical-stage biotech ABL Bio (Kosdaq: 298380) on Sunday announced a worldwide licensing agreement enabling GSK ...

ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology t ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative diseases.

A groundbreaking collagen-based dermal filler has officially launched in the Philippines, promising a new approach to facial ...

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has shared an update. Onco-Innovations Limited announced that its second-generation nanoparticle formulation ...

VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding ...

For married women and mothers who dream of joining pageants, Arlene Cris Damot believes nothing should hold them back.

This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.

Are you looking for a quick and effective way to revise for the CBSE Class 12 Biology Board Exam on March 25, 2025? With just one day left, smart and focused revision is crucial. To help you make the ...

She continued: "I've just booked my skin boosters which I think might help the elasticity in skin and polynucleotide for under eyes to rejuvenate. "It's a process but I'm so glad I've done it." ...